[PDF] Top 20 Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes

... ANOVA and x 2 tests or the Kruskal – Wallis rank test were used for comparisons of clinical characteristics between those with/ without FH, for each diagnosis ...Estimates of prevalence ... Voir le document complet

... (35% of patients) and for 1 year after DES place- ment (65% of patients); follow-up was for 1 ...VKA in half of the patients and one-third of them ... Voir le document complet

... Variations in international practice have indeed been previously described, 1,2,9–11 but have now also been demonstrated to extend to invasive management of the ...rate of cardiac ... Voir le document complet

... progress in the field of acute and chronic care of coronary heart disease, as well as its primary and secondary prevention, have been equal to this chal- lenge, and ... Voir le document complet

... 6826 patients in the UFH treated cohort, the 974 patients in the dalteparin cohort constituted a higher risk population as indicated by higher age and weight, more prior bypass surgery, ... Voir le document complet

... Department of Cardiology, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland Received 27 June 2013; revised 29 October 2013; accepted 21 November 2013; online publish-ahead-of-print 18 ... Voir le document complet

... Marco Roffi, Carlo Patrono, Jean-Philippe Collet, Christian Mueller, Marco Valgimigli, Felicita Andreotti, Jeroen J. Bax, Michael A. Borger, Carlos Brotons, Derek P. Chew, Baris Gencer, Gerd Hasenfuss, Keld Kjeldsen, ... Voir le document complet

... oils) in triglyceride management Statin treatment remains the first choice for managing high triglycerides (TG, >200 mg/dL or ...high-risk patients continue to present persistently elevated TG ... Voir le document complet

... common in hospitalized patients. In the context of acute coronary syndromes (ACS), TP has been linked to adverse clinical ...review and meta-analysis of the ... Voir le document complet

... ACS in patients but the mechanism involved in these acute complications remains undetermined, preventing effective therapies from being ...identification of perilipin 1 as a potential ... Voir le document complet

... strategies and outcomes There is a lack of prospective randomized investigations addressing the type ...incomplete) and timing (i.e. simultaneous vs. staged) of revascularization in ... Voir le document complet

... membrane and conceived as final common pathway of platelet ...class of potent antiplatelet agents in- terfering with this receptor with currently three agents available for ... Voir le document complet

... tolerated in this study and highly informative on early blood glucose excursions, sensor use to screen for hyperglycaemia in ACS represents a significant cost and would require some training ... Voir le document complet

... views with a limited number of physicians, it provides an interesting insight into the cost-structure of treating patients with acute coronary ...drivers in the ... Voir le document complet

... under-diagnosed and under-treated worldwide [ 1 ]. Up to 2013 in Belgium, only a fraction of HeFH carriers have been genetically characterized [ 2 e8 ...FH patients continue to suffer from ... Voir le document complet

... diagnosis and management of patients presenting with chest pain to the ED can be considerably improved by the implementation of new diagnostic clinical algorithms based on the ... Voir le document complet

... 16. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, Bouma B, Bruining N, Cho J, Chowdhary S, Costa MA, de Silva R, Dijkstra J, Di Mario C, Dudeck D, Falk E, Feldman MD, Fitzgerald P, Garcia H, ... Voir le document complet

... Use of a categorical rather than a continuous scoring system likely decreased the precision of the C-ACS ...preferable in emergency situations due to its ...covariates in the model to improve ... Voir le document complet

... evaluation of the efficacy of the lipid-lowering therapy initiated fol- lowing ACS should be performed early, with an LDL-C reduction target of >50% from ...agents with ... Voir le document complet

... encountered in 78.9% of STEMI patients and in 51.7% of NSTE-ACS patients in our ...NSTE-ACS patients presented with a higher prevalence ... Voir le document complet